InsidersTradesSigma
Track the Alligator Bioscience AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Alligator Bioscience AB has logged 2 reports. Market capitalisation: €22.8m. The latest transaction was reported on 22 September 2026 (Other). Among the most active insiders: Johan Giléus. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Alligator Bioscience AB is a biopharmaceutical company focused on developing immuno-oncology therapies. It aims to create innovative treatments for cancer.